Through these efforts, we now highlight chloride voltage-gated channel 2 (CLCN2) as a promising target for a specific dimension of cognition in early-stage psychosis, further supporting the utility of ONCs as a tool for the “druggable genome” approach in translational psychiatry. The gene discussed is CLCN2; the disease is psychotic disorder.